Reduced platelet monoamine oxidase type B activity and lymphocyte muscarinic receptor binding in unmedicated children with attention deficit hyperactivity disorder

References

• American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders: DSM-IVTR, 4th edn, text revision. Washington, DC: American Psychiatric Association.
   Google Scholar
• Anderson JC, Williams S, McGee R, Silva PA. (1987). DSM-III disorders in preadolescent children. Prevalence in a large sample from the general population. Arch Gen Psychiatry 44:69–76.
   PubMed Web of Science ®Google Scholar
• Anthenelli RM, Smith TL, Craig CE, Tabakoff B, Schuckit MA. (1995). Platelet monoamine oxidase activity levels in subgroups of alcoholics: diagnostic, temporal, and clinical correlates. Biol Psychiatry 38:361–8.
   PubMed Web of Science ®Google Scholar
• Arrojo M, Baca-Garcia E, Perez-Rodriguez MM, Dolengevich-Segal H, Navio-Acosta M, Rodriguez-Salgado B, Saiz-Ruiz J. (2007). Platelet monoamine oxidase activity in obsessive- compulsive disorder. Eur Psychiatry 22:525–9.
   PubMed Web of Science ®Google Scholar
• Baumgartel A, Wolraich ML, Dietrich M. (1995). Comparison of diagnostic criteria for attention deficit disorders in a German elementary school sample. J Am Acad of Child Adolesc Psychiatry 34:629–38.
   PubMed Web of Science ®Google Scholar
• Biederman J, Faraone SV. (2005). Attention-deficit hyperactivity disorder. Lancet 366:237–48.
   PubMed Web of Science ®Google Scholar
• Biederman J, Kwon A, Aleardi M, Chouinard VA, Marino T, Cole H, Mick E, Faraone SV. (2005). Absence of gender effects on attention deficit hyperactivity disorder:findings in nonreferred subjects. Am J Psychiatry 162:1083–9.
   PubMed Web of Science ®Google Scholar
• Biederman J, Mick E, Faraone SV, Braaten E, Doyle A, Spencer T, Wilens TE, Frazier E, Johnson MA. (2002). Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiatry 159:36–42.
   PubMed Web of Science ®Google Scholar
• Birmaher B, Khetarpal S, Brent D, Cully M, Balach L, Kaufman J, Neer SM. (1997). The Screen for Child Anxiety Related Emotional Disorders (SCARED): scale construction and psychometric characteristics. J Am Acad Child Adolesc Psychiatry 36:545–53.
   PubMed Web of Science ®Google Scholar
• Blanco C, Orensanz-Munoz L, Blanco-Jerez C, Saiz-Ruiz J. (1996). Pathological gambling and platelet MAO activity:a psychobiological study. Am J Psychiatry 153:119–21.
   PubMed Web of Science ®Google Scholar
• Carrasco JL, Diaz-Marsa M, Hollander E, Cesar J, Saiz-Ruiz J. (2000). Decreased platelet monoamine oxidase activity in female bulimia nervosa. Eur Neuropsychopharmacol 10:113–17.
   PubMed Web of Science ®Google Scholar
• Coccini T, Castoldi AF, Gandini C, Randine G, Vittadini G, Baiardi P, Manzo L. (2002). Platelet monoamine oxidase B activity as a state marker for alcoholism: trend over time during withdrawal and influence of smoking and gender. Alcohol Alcohol 37:566–72.
   PubMed Web of Science ®Google Scholar
• Coccini T, Randine G, Castoldi AF, Balloni L, Baiardi P, Manzo L. (2005). Lymphocyte muscarinic receptors and platelet monoamine oxidase-B as biomarkers of CNS function. Effects of age and gender in healthy humans. Environ Toxicol Pharmacol 19:715–20.
   PubMed Web of Science ®Google Scholar
• Conners CK. (1997). Conners’ Rating Scales – Revised: Technical manual. Toronto, Ontario, Canada: Multi-Health Systems Inc.
   Google Scholar
• Cubo E, Fern Ndez Jaén A,Moreno C, Anaya B, Gonz Lez M, Kompoliti K. (2008). Donepezil use in children and adolescents with tics and attention-deficit/hyperactivity disorder: an 18-week, single-center, dose-escalating, prospective, open- label study. Clin Ther 30:182–189.
   PubMed Web of Science ®Google Scholar
• Danielczyk W, Streifler M, Konrad C, Riedere P, Moil G. (1988). Platelet MAO-B activity and the psychopathology of Parkinson’s disease, senile dementia and multi-infarct dementia. Acta Psychiatr Scand 78:730–6.
   PubMed Web of Science ®Google Scholar
• Dick DM, Aliev F, Kramer J, Wang JC, Anthony Hinrichs A, Bertelsen S, Kuperman S, Schuckit M, Nurnberger Jr J. Edenberg HJ, Porjesz B, Begleiter H, Hesselbrock V, Goate A, Bierut L. (2007). Association of CHRM2 with IQ:Converging evidence for a gene influencing intelligence. Behav Genet 37:265–72.
   PubMed Web of Science ®Google Scholar
• Doyle RL, Frazier J, Spencer TJ, Geller D, Biederman J, Wilens T. (2006). Donepezil in the treatment of ADHD-like symptoms in youths with pervasive developmental disorder: a case series. J Atten Disord 9:543–9.
   PubMedGoogle Scholar
• Faraone SV, Biederman J. (2002). Pathophysiology of Attention-Deficit/Hyperactivity Disorder. In: Davis KL, Charney D, Coyle JT, Nemeroff C, editors. Neuropsychopharmacology: The Fifth Generation of Progress. Philadelphia, PA: Lippincott WIlliams & Wilkins. p. 577–96.
   Google Scholar
• Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P. (2005). Molecular genetics of attention deficit/hyperactivity disorder. Biol Psychiatry 57:1313–23.
   PubMed Web of Science ®Google Scholar
• Faraone SV, Sergeant J, Gillberg C, Biederman J. (2003). The worldwide prevalence of ADHD: is it an American condition? World Psychiatry 2:104–13.
   PubMedGoogle Scholar
• Fahlke C, Garpenstrand H, Oreland L, Suomi SJ, Higley JD. (2002). Platelet monoamine oxidase activity in a nonhuman primate model of type 2 excessive alcohol consumption. Am J Psychiatry 159:2107–9.
   PubMed Web of Science ®Google Scholar
• Fujii T, Takada-Takatori Y, Kawashima K. (2008). Basic and clinical aspects of non-neuronal acetylcholine: expression of an independent, non-neuronal cholinergic system in lymphocytes and its clinical significance in immunotherapy. J Pharmacol Sci 106:186–92.
   PubMedGoogle Scholar
• Fujimoto K, Matsui M, Fujii T, Kawashima K. (2001). Decreased acetylcholine content and choline acetyltransferase mRNA expression in circulating mononuclear leukocytes and lymphoid organs of the spontaneously hypertensive rat. Life Sci 69:1629–38.
   PubMedGoogle Scholar
• Halperin JM, Newcorn JH, Schwartz ST, Sharma V, Siever LJ, Koda VH, Gabriel S. (1997). Age-related changes in the association between serotonergic function and aggression in boys with ADHD. Biol Psychiatry 41:682–9.
   PubMedGoogle Scholar
• Hand DJ, Fox AT, Reilly MP. (2006). Response acquisition with delayed reinforcement in a rodent model of attention-deficit/ hyperactivity disorder (ADHD). Behav Brain Res 175:337–42.
   PubMedGoogle Scholar
• Hercigonja Novkovic V, Rudan V, Pivac N, Nedic G, Muck-Seler D. (2009). Platelet serotonin concentration in children with attention-deficit/hyperactivity disorder. Neuropsychobiology 59:17–22.
   PubMedGoogle Scholar
• Kaneda Y, Fujii A, Nagamine I. (2001). Platelet serotonin concentrations in medicated schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry 25:983–92.
   PubMed Web of Science ®Google Scholar
• Kaufman J, Birmaher B, Brent D, Rao U, Ryan N. (1996). Kiddie-SADS-Present and Lifetime Version (KSADS-PL), version 1.0 of October, 1996 edn. Pittsburgh, PA: Department of Psychiatry, University of Pittsburgh School of Medicine, University of Pittsburgh Press.
   Google Scholar
• Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N. (1997). Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980–88.
   PubMed Web of Science ®Google Scholar
• Kawashima K, Fujii T. (2000). Extraneuronal cholinergic system in lymphocytes. Pharmacol Ther 86:29–48.
   PubMed Web of Science ®Google Scholar
• Kiive E, Fischer K, Harro M, Harro J. (2007). Platelet monoamine oxidase activity in association with adolescent inattentive and hyperactive behaviour: a prospective longitudinal study. Pers Individ Dif 43:155–66.
   Google Scholar
• Leblond L, Beaufort C, Delerue F, Durkin TP. (2002). Differential roles for nicotinic and muscarinic cholinergic receptors in sustained visuo-spatial attention? A study using a 5-arm maze protocol in mice. Behav Brain Res 128:91–102.
   PubMed Web of Science ®Google Scholar
• Levine RR, Birdsall NJM, Nathanson NM, editors. (2001). Proceedings of the Ninth International Symposium on Subtypes of Muscarinic Receptors. Life Sci 68:2449–642.
   Google Scholar
• Li J, Kang C, Zhang H, Wang Y, Zhou R, Wang B, Guan L, Yang L, Faraone SV. (2007). Monoamine oxidase a gene polymorphism predicts adolescent outcome of attention-deficit/ hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genetic 144B:430–3.
   PubMedGoogle Scholar
• Malmberg K, Wargelius HL, Lichtenstein P, Oreland L, Larsson JO. (2008). ADHD and disruptive behavior scores – associations with MAO-A and 5-HTT genes and with platelet MAO-B activity in adolescents. BMC Psychiatry 8:28.
   PubMed Web of Science ®Google Scholar
• Manzo L, Artigas F, Martinez E, Mutti A, Bergamaschi E, Nicotera P, Tonini M, Candura SM, Ray DE, Costa LG. (1996). Biochemical markers of neurotoxicity. A review of mechanistic studies and applications. Hum Exp Toxicol 15:S20–S35.
   Web of Science ®Google Scholar
• Manzo L, Castoldi AF, Coccini T, Prockop LD. (2001). Assessing effects of neurotoxic pollutants by biochemical markers. Environ Res 85:31–6.
   PubMed Web of Science ®Google Scholar
• Masuyama K, Uno K, Minoda R, Eura M, Samejima Y, Ishikawa T. (1996). Muscarinic acetylcholine receptors in patients with Meniere’s disease. Acta Oto-Laryngol (Stockholm) 116:369–73.
   PubMed Web of Science ®Google Scholar
• Mitsis EM, Halperin JM, Newcorn JH. (2000). Serotonin and aggression in children. Curr Psychiatry Rep 2:95–101.
   PubMedGoogle Scholar
• Nass RD. (2005). Evaluation and assessment issues in the diagnosis of attention deficit hyperactivity disorder. Seminars in Pediatric Neurology 12:200–16.
   PubMedGoogle Scholar
• Oades RD. (2008). Dopamine-serotonin interactions in attention- deficit hyperactivity disorders (ADHD). Prog Brain Res 172:543–65.
   PubMed Web of Science ®Google Scholar
• Oreland L. (2004). Platelet monoamine oxidase, personality and alcoholism: the rise, fall and resurrection. NeuroToxicology 25:79–89.
   PubMed Web of Science ®Google Scholar
• Oreland L, Hallman J, Damberg M. (2004). Platelet MAO and personality – function and dysfunction. Curr Med Chem 11:2007–16.
   PubMedGoogle Scholar
• Oreland L, Nilsson K, Damberg M, Hallman J. (2007). Monoamine oxidases – activities, genotypes and the shaping of behaviour. J Neural Transm 114:817–22.
   PubMed Web of Science ®Google Scholar
• Pardey MC, Homewood J, Taylor A, Cornish JL. (2009). Re-evaluation of an animal model for ADHD using a free-operant choice task. J Neurosci Methods 176:166–71.
   PubMedGoogle Scholar
• Poznanski EO, Grossman JA, Buchsbaum Y, Banegas M, Freeman L, Gibbons R. (1984). Preliminary studies of the reliability and validity of the children’s depression rating scale. J Am Acad Child Psychiatry 23:191–7.
   PubMedGoogle Scholar
• Rabey JM, Grynberg E, Graff E. (1991). Changes of muscarinic cholinergic binding by lymphocyte in Parkinson’s disease with and without dementia. Ann Neurol 30:847–50.
   PubMed Web of Science ®Google Scholar
• Rabey JM, Lewis A, Graff E, Korczyn AD. (1992). Decreased (3H) quinuclidinyl benzilate binding to lymphocytes in Gilles de la Tourette syndrome. Biol Psychiatry 31:889–95.
   PubMed Web of Science ®Google Scholar
• Ramoz N, Boni C, Downing AM, Close SL, Peters SL, Prokop AM, Allen AJ, Hamon M, Purper-Ouakil D, Gorwood P. (2009). A haplotype of the norepinephrine transporter (Net) gene Slc6a2 is associated with clinical response to atomoxetine in attention-deficit hyperactivity disorder (ADHD). Neuropsychopharmacology. Apr 22. Epub ahead of print.
   Google Scholar
• Ruchkin VV, Koposov RA, Klinteberg B, Oreland L, Grigorenko EL. (2005). Platelet MAO-B, Personality, and Psychopathology. J Abnormal Psychology 114:477–82.
   PubMed Web of Science ®Google Scholar
• Sagvolden T, Johansen EB, Aase H, Russell VA. (2005a). A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes. Behav Brain Sci 28:397–419.
   PubMed Web of Science ®Google Scholar
• Sagvolden T, Russell VA, Aase H, Johansen EB, Farshbaf M. (2005b). Rodent models of attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1239–47.
   PubMed Web of Science ®Google Scholar
• Shekim WO, Bylund DB, Alexson J, Glaser RD, Jones SB, Hodges K, Perdue S. (1986). Platelet MAO and measures of attention and impulsivity in boys with attention deficit disorder and hyperactivity. Psychiatry Res 18:179–88.
   PubMedGoogle Scholar
• Snell LD, Glanz J, Tabakoff B. (2002). Relationships between effects of smoking, gender, and alcohol dependence on platelet monoamine oxidase-B: activity, affinity labelling, and protein measurements. Alcohol Clin Exp Res 26:1105–13.
   PubMed Web of Science ®Google Scholar
• Swanson JM, Sandman CA, Deutsch C, Baren M. (1983). Methylphenidate hydrochloride given with or before breakfast: behavioral, cognitive, and electrophysiological effects. Pediatrics 72:49–55.
   PubMed Web of Science ®Google Scholar
• Swanson JM, Sergeant JA, Taylor E, Sonuga-Barke EJ, Jensen PS, Cantwell DP. (1998). Attention deficit hyperactivity disorder and hyperkinetic disorder. Lancet 351:429–33.
   PubMed Web of Science ®Google Scholar
• Tayebati SK, Codini M, Gallai V, Mannino F, Parnetti L, Ricci A, Sarchielli P, Amenta F. (1999). Radioligand binding assay of M1-M5 muscarinic cholinergic receptor subtypes in human peripheral blood lymphocytes. J Neuroimmunol 99:224–9.
   PubMed Web of Science ®Google Scholar
• Tayebati SK, Amenta F, Amici S, El-Assouad D, Gallai V, Ricci A, Parnetti L. (2001). Peripheral blood lymphocytes muscarinic cholinergic receptor subtypes in Alzheimer’s disease: a marker of cholinergic dysfunction? J Neuroimmunol 121:126–31.
   PubMed Web of Science ®Google Scholar
• Tzavara ET, Bymaster FP, Overshiner CD, Davis RJ, Perry KW, Wolff M, McKinzie DL, Witkin JM, Nomikos GG. (2006). Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetine. Mol Psychiatry 11:187–95.
   PubMed Web of Science ®Google Scholar
• Vakalopoulos C. (2006). Neuropharmacology of cognition and memory: a unifying theory of neuromodulator imbalance in psychiatry and amnesia. Med Hyp 66:394–431.
   PubMed Web of Science ®Google Scholar
• Vakalopoulos C. (2007). Neurocognitive deficits in major depression and a new theory of ADHD: a model of impaired antagonism of cholinergic-mediated prepotent behaviours in monoamine depleted individuals. Med Hyp 68:210–21.
   PubMedGoogle Scholar
• Verkes RJ, Van der Mast RC, Kerkhof AJ, Fekkes D, Hengeveld MW, Tuyl JP, Van Kempen GM. (1998). Platelet serotonin, monoamine oxidase activity, and 3H paroxetine binding related to impulsive suicide attempts and borderline personality disorder. Biol Psychiatry 15:740–6.
   Web of Science ®Google Scholar
• Weiss M, Weiss G. (2002). Attention deficit hyperactivity disorder. In: Lewis M, editor. Child and Adolescent Psychiatry, a Comprehensive Textbook, 3rd edn. Baltimore: Williams & Wilkins. p. 645–69.
   Google Scholar
• Weizman R, Weizman A, Deutsch SI. 1990. Biological studies of attention-deficit disorder. In: Deutsch SI, Weizman A, Weizman R. (Eds.), Application of Basic Neuroscience to Child Psychiatry. Plenum co., New York, pp. 231–239.
   Google Scholar
• Wess J. (2003). Novel insights into muscarinic acetylcholine receptor function using gene targeting technology. TRENDS Pharmacol Sci 24:414–20.
   PubMed Web of Science ®Google Scholar
• Wess J, Eglen RM, Gautam D. (2007). Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development. Nat Rev Drug Discov 6:721–33.
   PubMed Web of Science ®Google Scholar
• Wilens TE, Biederman J, Wong J, Spencer TJ, Prince JB. (2000). Adjunctive donepezil in attention deficit hyperactivity disorder youth: case series. J Child Adolesc Psychopharmacol 10:217–22.
   PubMed Web of Science ®Google Scholar
• Wilens TE, Verlinden MH, Adler LA, Wozniak PJ, West SA. (2006). ABT-089, a neuronal nicotinic receptor partial agonist, for the treatment of attention-deficit/hyperactivity disorder in adults: results of a pilot study. Biol Psychiatry 59:1065–70.
   PubMed Web of Science ®Google Scholar